The influence of anemia after percutaneous coronary intervention on clinical outcomes

Clinical Cardiology

Volumn 32, Issue 7, 2009, Pages 373-379

  Sattur, Sudhakar ^a   Harjai, Kishore J ^b   Narula, Arvin ^b   Devarakonda, Srinivas ^b   Orshaw, Pamela ^b   Yaeger, Karl ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b GUTHRIE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD TRANSFUSION; BLOOD VESSEL; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; FEMALE; HAZARD RATIO; HEART INFARCTION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PROGNOSIS; REVASCULARIZATION;

AGED; AGED, 80 AND OVER; ANEMIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD TRANSFUSION; DOWN-REGULATION; FEMALE; HEMOGLOBINS; HEMORRHAGE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67749111730     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20542     Document Type: Article

References (26)

1. O'Neill WW. Risk of bleeding after elective percutaneous coronary intervention. N Engl J Med. 2006;355:1058-1060. (Pubitemid 44343552)
2. PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes: Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med. 1998;339: 436-443.
3. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase clinical findings through hospital discharge. Circulation. 1987;76:142-154. (Pubitemid 17093202)
4. Hill ME, Rosenwaike I. The Social Security Administration Death Master File: the completeness of death reporting at older ages. Soc Secur Bulletin. 2001;64:45-51. (Pubitemid 33691390)
5. Turner SJ, Ketch TR, Gandhi SK, Sane DC. Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. Am Heart J. 2008;155:806-816.
6. McKechnie RS, Smith D, Montoye C, et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation. 2004;110:271-277. (Pubitemid 38955496)
7. Voeltz MD, Patel AD, Feit F, et al. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol. 2007;99:1513-1517. (Pubitemid 46770636)
8. Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol. 2003; 92:930-935. (Pubitemid 37214804)
9. Lincoff AM, Bittl JA, Kleiman NS, et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). Am J Cardiol. 2004;93: 1092-1096.
10. Rao SV, O'Grady K, Pieper KS, et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol. 2006; 47:809-816. (Pubitemid 43243106)
11. Rao TLK, Montoya A. Cardiovascular, electrocardiographic and respiratory changes following acute anemia with volume replacement in patients with coronary artery disease. Anesth Dev. 1985;12:49-54.
12. Mangano DT, Browner WS, Hollenberg M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med. 1990;323:1781-1788.
13. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230-1236. (Pubitemid 34951486)
14. Fortune JB, Feustel PJ, Saifi J, et al. Influence of hematocrit on cardiopulmonary function after acute hemorrhage. J Trauma. 1987;27:243-247. (Pubitemid 17065456)
15. Casutt M, Seifert B, Pasch T, et al. Factors influencing the individual effects of blood transfusions on oxygen delivery and oxygen consumption. Crit Care Med. 1999;27:2194-2200. (Pubitemid 29508337)
16. Greenburg AG. A physiologic basis for red blood cell transfusion decisions. Am J Surg. 1995;170:S S 44-48.
17. Balla J, Jacob HS, Balla G, et al. Cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA. 1993;90:9285-9289.
18. Blachman MA. Transfusion associated immunomodulation and universal white cell reduction: are we putting the cart before the horse. Transfusion. 1999;39:1-9.
19. Hebert PC, Wells G, Blajchman MA, et al; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999; 340:409-417.
20. Hebert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001;29:227-234. (Pubitemid 32171763)
21. Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation. 2007;116(5):471-479. (Pubitemid 47450255)
22. Carson JL, Terrin ML, Barton FB, et al. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion. 1998;38 522-529.
23. Dunkelgrun M, Hoeks SE, Welten GM, et al. Anemia as an independent predictor of perioperative and long-term cardiovascular outcome in patients scheduled for elective vascular surgery. Am J Cardiol. 2008;101:1196-1200.
24. Weiner DE, Tighiouart H, Vlagopoulos PT, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol. 2005;16: 1803-1810. (Pubitemid 41716487)
25. Anand I, McMurray JJ, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004; 110(2):149-154. (Pubitemid 38924582)
26. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.